SPG
53
-2
WDC
49
-3
LEG
29
4
SBUX
41
-3
COST
51
-3
CCL
71
4
AAL
47
-3
MSFT
54
-3
SRE
54
-5
TRIP
60
3
PWR
60
-2
UNP
48
-2
HRL
38
2
LB
41
-11
ETR
68
-3
XOM
48
3
CRM
50
-5
VRTX
56
-4
UHS
58
4
O
35
-2
SPG
53
-2
WDC
49
-3
LEG
29
4
SBUX
41
-3
COST
51
-3
CCL
71
4
AAL
47
-3
MSFT
54
-3
SRE
54
-5
TRIP
60
3
PWR
60
-2
UNP
48
-2
HRL
38
2
LB
41
-11
ETR
68
-3
XOM
48
3
CRM
50
-5
VRTX
56
-4
UHS
58
4
O
35
-2
Financhill
Back

Chugai Pharmaceutical 10K Form

Sell
42

CHGCY
Chugai Pharmaceutical

Last Price:
24.04
Seasonality Move:
2%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CHGCY News And Ratings

See the #1 stock for the next 7 days that we like better than CHGCY

CHGCY Financial Statistics

Sales & Book Value

Annual Sales: $7.92B
Cash Flow: $281.99M
Price / Cash Flow: 44.59
Annual Sales: $3.31
Price / Book: 7.16

Profitability

EPS (TTM): 0.72120
Net Income (TTM): $2.37B
Gross Margin: $4.98B
Return on Equity: 21.98%
Return on Assets: 18.58%

Chugai Pharmaceutical Earnings Forecast

Key Chugai Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 21 years for CHGCY is 62.81%.
  • The Selling, General & Administrative Expenses for CHGCY have been equal to 10.13% of Gross Profit Margin.
  • The Research & Development expenses have been 15.73% of Revenue.
  • The Interest Expense is 0.01% of Operating Income.
  • The Net Earning history of CHGCY is 29.29% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 13 years.

Chugai Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CHGCY
Website: chugai-pharm.co.jp

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.09
Quick Ratio: 4.02

Price-to-Earnings

Trailing P/E Ratio: 33.58
Forward P/E Ratio: 0

CHGCY Technical Analysis vs Fundamental Analysis

Sell
42
Chugai Pharmaceutical (CHGCY) is a Sell

Is Chugai Pharmaceutical a Buy or a Sell?